X
Denmark’s Genmab raises a bumper $500m-plus in Nasdaq IPO
https://pharmaphorum.com/news/denmarks-genmab-raises-a-bumper-500m-plus-in-nasdaq-ipo/
bispecific antibody
Novartis buys into bispecific antibodies with Xencor deal
Agreement could add to Novartis’ immuno-oncology pipeline.